{"id":"W2619012808","doi":"10.1080/10428194.2017.1326034","title":"Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus","year":2017,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"Janssen Research and Development","keywords":"Ibrutinib; Mantle cell lymphoma; Temsirolimus; Medicine; Quality of life (healthcare); Internal medicine; Oncology; Clinical trial; Lymphoma; Phases of clinical research; Randomized controlled trial; Leukemia; Discovery and development of mTOR inhibitors; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004936032,0.0007199483,0.001771208,0.0004116687,0.0004137602,0.0007858887,0.0005607581,0.0008394403,0.002672479],"category_scores_gemma":[0.003033828,0.0002906163,0.00226473,0.0007207281,0.0007009709,0.0008631331,0.0004457905,0.001984492,0.0003153242],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004914054,"about_ca_system_score_gemma":0.0006997032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006507809,"about_ca_topic_score_gemma":0.001172848,"domain_scores_codex":[0.9976785,0.001615967,0.000184947,0.0001661644,0.0001829477,0.0001715952],"domain_scores_gemma":[0.9966477,0.0009963871,0.001061338,0.0002697467,0.0002376294,0.0007873022],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9189934,0.01565931,0.02732107,0.0005800856,0.006291208,0.00005978617,0.0001511798,0.0009756055,0.005283891,0.0001304674,0.001402194,0.02315184],"study_design_scores_gemma":[0.5977524,0.2561932,0.1356259,0.0001014883,0.004504807,0.0001431818,0.000150851,0.001041579,0.001938717,0.0001700177,0.002322686,0.00005524088],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920716,0.002648087,0.0003642007,0.0002417785,0.00006759393,0.001006174,0.002457125,0.00001802693,0.001125394],"genre_scores_gemma":[0.9914527,0.0008058849,0.0005455845,0.0004014307,0.00008750455,0.001521426,0.004736444,0.000009125169,0.000439949],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004936032,"threshold_uncertainty_score":0.02610451,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07370496193561728,"score_gpt":0.3693687295541824,"score_spread":0.2956637676185651,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}